Company Filing History:
2 out of 38 
2 out of 5,081 
2 out of 154 
Years Active: 2019-2023
Title: Michael Hahne: Innovator in Inflammatory Disease Treatment
Introduction
Michael Hahne is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of inflammatory diseases. With a total of 2 patents to his name, Hahne's work is recognized for its potential impact on healthcare.
Latest Patents
Hahne's latest patents focus on the use of quinoline derivatives for the treatment of inflammatory diseases. The first patent discloses the use of a compound of formula (I) or its pharmaceutically acceptable salts in the treatment and/or prevention of inflammatory diseases. The second patent also relates to a compound of formula (I) with similar applications. Both patents emphasize the importance of specific chemical groups and their configurations in developing effective treatments.
Career Highlights
Throughout his career, Michael Hahne has worked with prominent organizations such as Abivax and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Hahne's notable coworkers include Jamal Tazi and Romain Najman. Their collaborative efforts have further advanced the research and development of innovative treatments for inflammatory diseases.
Conclusion
Michael Hahne's contributions to the field of medicinal chemistry, particularly through his patents on quinoline derivatives, highlight his role as an innovator in the treatment of inflammatory diseases. His work continues to inspire advancements in healthcare solutions.